333 related articles for article (PubMed ID: 30660504)
1. Therapeutic Dissolution of Aberrant Phases by Nuclear-Import Receptors.
Guo L; Fare CM; Shorter J
Trends Cell Biol; 2019 Apr; 29(4):308-322. PubMed ID: 30660504
[TBL] [Abstract][Full Text] [Related]
2. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.
Guo L; Kim HJ; Wang H; Monaghan J; Freyermuth F; Sung JC; O'Donovan K; Fare CM; Diaz Z; Singh N; Zhang ZC; Coughlin M; Sweeny EA; DeSantis ME; Jackrel ME; Rodell CB; Burdick JA; King OD; Gitler AD; Lagier-Tourenne C; Pandey UB; Chook YM; Taylor JP; Shorter J
Cell; 2018 Apr; 173(3):677-692.e20. PubMed ID: 29677512
[TBL] [Abstract][Full Text] [Related]
3. Nuclear-Import Receptors Counter Deleterious Phase Transitions in Neurodegenerative Disease.
Odeh HM; Fare CM; Shorter J
J Mol Biol; 2022 Jan; 434(1):167220. PubMed ID: 34464655
[TBL] [Abstract][Full Text] [Related]
4. Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD.
Khalil B; Linsenmeier M; Smith CL; Shorter J; Rossoll W
Mol Neurodegener; 2024 Jan; 19(1):8. PubMed ID: 38254150
[TBL] [Abstract][Full Text] [Related]
5. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
6. Regulating Phase Transition in Neurodegenerative Diseases by Nuclear Import Receptors.
Girdhar A; Guo L
Biology (Basel); 2022 Jul; 11(7):. PubMed ID: 36101390
[TBL] [Abstract][Full Text] [Related]
7. Beyond the Transport Function of Import Receptors: What's All the FUS about?
Mikhaleva S; Lemke EA
Cell; 2018 Apr; 173(3):549-553. PubMed ID: 29677508
[TBL] [Abstract][Full Text] [Related]
8. A minimal construct of nuclear-import receptor Karyopherin-β2 defines the regions critical for chaperone and disaggregation activity.
Fare CM; Rhine K; Lam A; Myong S; Shorter J
J Biol Chem; 2023 Feb; 299(2):102806. PubMed ID: 36529289
[TBL] [Abstract][Full Text] [Related]
9. Hormone-Inducible Transport Reporter Assay to Study Nuclear Import Defects in Neurodegenerative Diseases.
Hutten S; Dormann D
Methods Mol Biol; 2022; 2502():81-90. PubMed ID: 35412232
[TBL] [Abstract][Full Text] [Related]
10. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation.
Hofweber M; Hutten S; Bourgeois B; Spreitzer E; Niedner-Boblenz A; Schifferer M; Ruepp MD; Simons M; Niessing D; Madl T; Dormann D
Cell; 2018 Apr; 173(3):706-719.e13. PubMed ID: 29677514
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Import Receptors Directly Bind to Arginine-Rich Dipeptide Repeat Proteins and Suppress Their Pathological Interactions.
Hutten S; Usluer S; Bourgeois B; Simonetti F; Odeh HM; Fare CM; Czuppa M; Hruska-Plochan M; Hofweber M; Polymenidou M; Shorter J; Edbauer D; Madl T; Dormann D
Cell Rep; 2020 Dec; 33(12):108538. PubMed ID: 33357437
[TBL] [Abstract][Full Text] [Related]
12. Phase separation and pathologic transitions of RNP condensates in neurons: implications for amyotrophic lateral sclerosis, frontotemporal dementia and other neurodegenerative disorders.
Naskar A; Nayak A; Salaikumaran MR; Vishal SS; Gopal PP
Front Mol Neurosci; 2023; 16():1242925. PubMed ID: 37720552
[TBL] [Abstract][Full Text] [Related]
13. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.
March ZM; King OD; Shorter J
Brain Res; 2016 Sep; 1647():9-18. PubMed ID: 26996412
[TBL] [Abstract][Full Text] [Related]
14. RNA modulates physiological and neuropathological protein phase transitions.
Mann JR; Donnelly CJ
Neuron; 2021 Sep; 109(17):2663-2681. PubMed ID: 34297914
[TBL] [Abstract][Full Text] [Related]
15. Transportin-1 and Transportin-2: protein nuclear import and beyond.
Twyffels L; Gueydan C; Kruys V
FEBS Lett; 2014 May; 588(10):1857-68. PubMed ID: 24780099
[TBL] [Abstract][Full Text] [Related]
16. C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers.
Nanaura H; Kawamukai H; Fujiwara A; Uehara T; Aiba Y; Nakanishi M; Shiota T; Hibino M; Wiriyasermkul P; Kikuchi S; Nagata R; Matsubayashi M; Shinkai Y; Niwa T; Mannen T; Morikawa N; Iguchi N; Kiriyama T; Morishima K; Inoue R; Sugiyama M; Oda T; Kodera N; Toma-Fukai S; Sato M; Taguchi H; Nagamori S; Shoji O; Ishimori K; Matsumura H; Sugie K; Saio T; Yoshizawa T; Mori E
Nat Commun; 2021 Sep; 12(1):5301. PubMed ID: 34489423
[TBL] [Abstract][Full Text] [Related]
17. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Guo L; Shorter J
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920024
[TBL] [Abstract][Full Text] [Related]
18. The N-terminal nuclear localization sequences of liver X receptors alpha and beta bind to importin alpha and are essential for both nuclear import and transactivating functions.
Miller A; Crumbley C; Prüfer K
Int J Biochem Cell Biol; 2009 Apr; 41(4):834-43. PubMed ID: 18773967
[TBL] [Abstract][Full Text] [Related]
19. Phase separation of RNA-binding proteins in physiology and disease: An introduction to the JBC Reviews thematic series.
Shorter J
J Biol Chem; 2019 May; 294(18):7113-7114. PubMed ID: 30948513
[TBL] [Abstract][Full Text] [Related]
20. Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.
Guo L; Mann JR; Mauna JC; Copley KE; Wang H; Rubien JD; Odeh HM; Lin J; Lee BL; Ganser L; Robinson E; Kim KM; Murthy AC; Paul T; Portz B; Gleixner AM; Diaz Z; Carey JL; Smirnov A; Padilla G; Lavorando E; Espy C; Shang Y; Huang EJ; Chesi A; Fawzi NL; Myong S; Donnelly CJ; Shorter J
bioRxiv; 2023 Sep; ():. PubMed ID: 37732211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
